metastatic gastric cancer: factors in selecting frontline therapy
Published 4 years ago • 350 plays • Length 4:12Download video MP4
Download video MP3
Similar videos
-
4:15
global use of frontline therapy in metastatic gastric cancer
-
7:26
is frontline io therapy appropriate in gastric cancer?
-
5:47
choosing frontline therapy in metastatic disease
-
5:40
advanced/metastatic gastric cancer: beyond frontline
-
4:50
metastatic gastric cancer: promising frontline trials
-
7:02
later lines of therapy in metastatic gastric cancer
-
8:04
perioperative strategies in metastatic gastric cancer
-
5:34
metastatic gastric cancer: identifying disease progression
-
7:59
metastatic gastric cancer: promising later-line trials
-
5:26
metastatic gastric cancer: promising second-line trials
-
5:16
goals of therapy in metastatic gastric/gej cancer
-
20:04
metastatic gastric cancer: new targeted agents in metastatic gastric cancer
-
1:41
frontline approach in gastric cancer: double vs triplet
-
0:58
dr. mehta on the role of biomarkers in gastric cancer
-
5:54
gastric cancer: global perspectives on maintenance therapy
-
5:40
patient selection for immunotherapy in gastric cancer
-
3:03
gastric cancer: frontline checkpoint inhibitor trials
-
5:24
emerging biomarkers in metastatic gastric cancer
-
6:19
immunotherapy in advanced/metastatic gastric/gej cancers